C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2001
11/21/2001	EP1156118A1 Virus vector
11/21/2001	EP1156112A1 Synthetic gagpol genes and their uses
11/21/2001	EP1156111A1 Chimeric arterivirus-like particles
11/21/2001	EP1156102A1 Immunodeficiency virus recombinant poxvirus vaccine
11/21/2001	EP1155120A1 Method for obtaining a purified viral preparation
11/21/2001	EP1155119A1 Bhv-1 gene-deleted virus vaccine
11/21/2001	EP1154827A1 Purification of biological substances
11/21/2001	CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof
11/21/2001	CN1322840A Glandular associated viral vector and its prepn and use
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319713 Methods and compositions for polypeptide engineering
11/20/2001	US6319703 Recombinant virus vectors
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/18/2001	CA2322057A1 Paramyxovirus vectors used for transfer of foreign genes
11/15/2001	WO2001085974A2 Retroviral vectors comprising an enhanced 3' transcription termination structure
11/15/2001	WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	WO2001085919A1 Hiv-producing cell line and use thereof
11/15/2001	WO2001085770A2 Sentinel virus ii
11/15/2001	WO2001011065A3 Hepatitis a virus clones adapted for growth in agmk cells
11/15/2001	WO2000075352A3 Hcv/bvdv chimeric genomes and uses thereof
11/15/2001	WO2000054730A3 Compositions preparations and uses of human papillomavirus l1 protein
11/15/2001	US20010041361 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/15/2001	US20010041354 Genetic engineering
11/15/2001	US20010041173 Helper-dependent cloning vectors where most viral genes have been removed and have increased safety and capacity for larger insertions
11/15/2001	DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001	CA2407955A1 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	CA2406644A1 Sentinel virus ii
11/14/2001	EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
11/14/2001	EP1152773A1 Methods of inactivating pathogens using broad-spectrum pulsed light
11/14/2001	CN1322251A Mutant human hepatitis B viral strain and uses thepeof
11/13/2001	US6316424 Sulfated phosphatidylinositols, their preparation and use of the same
11/13/2001	US6316243 Viral nucleotide sequences; for the reduction or prevention of viral infection
11/13/2001	US6316183 Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)
11/08/2001	WO2001083797A2 Polynucleotides for use in recombinant adeno-associated virus virion production
11/08/2001	WO2001083794A2 Dna transfection system for the generation of infectious influenza virus
11/08/2001	WO2001083747A2 Prion proteins and their uses
11/08/2001	WO2001083730A2 Recombinant lentiviral vectors pseudotyped in envelopes containing filovirus binding domains
11/08/2001	WO2001083711A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
11/08/2001	WO2001083710A2 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	WO2001083692A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001041801A3 Mutant simplex virus for treating unwanted hyperproliferative cell growth
11/08/2001	WO2001023414A3 Immunologically significant herpes simplex virus antigens
11/08/2001	WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics
11/08/2001	US20010039669 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
11/08/2001	US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
11/08/2001	US20010039048 Recombinant adenovirus and its use for the prevention and treatment of fibrotic disease
11/08/2001	US20010039046 Genetically engineered adenovirus comprising a genome whose E1 region is deactivated, whose organization is modified and the recombination of which with the genome of the producing line leads to the new viral vectors; gene therapy
11/08/2001	US20010039044 Transfecting cells with a recombinant adeno-associated virus (AAV) which can be package into infectious AAV virions, a helper AAV vector essential for replication and packaging and a productive vector which cannot be packaged into the virion
11/08/2001	CA2712368A1 Dna transfection system for the generation of infectious influenza virus
11/08/2001	CA2605803A1 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2406743A1 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/07/2001	EP1152243A1 DIagnosis of Sjögren's syndrome, systemic lupus erythematosis, and scleroderma via detection of anti-retroviral antibodies
11/07/2001	EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
11/07/2001	EP1151121A1 Recombined porcine adenovirus based viral vaccines and vectors
11/07/2001	EP1151091A1 Improved helper dependent vector system for gene therapy
11/07/2001	CN1321199A Cell lines for propagation of mutated herpes viruses
11/07/2001	CN1321193A RNA virus vector having contact infiltration capability
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/06/2001	US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction
11/06/2001	US6312946 Viable contaminant particle free adenoviruses, their prepartion and use
11/06/2001	US6312931 Preventing degradation of preferential bioploymers; provide sample with parasite or toxin, mix albumin, expose mixture to polychromatic pulse, recover biopolymers
11/06/2001	US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease
11/06/2001	US6312683 Equine infectious anemia virus vectors
11/06/2001	US6312682 Retroviral vectors
11/01/2001	WO2001081569A2 Heparanase ii, a human heparanase paralog
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081553A1 Alphavirus-based vectors for persistent infection
11/01/2001	WO2001081375A2 Dna & protein binding miniature proteins
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv
11/01/2001	WO2001027301A3 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
11/01/2001	US20010036657 Aqueous solution; ion exchanging
11/01/2001	US20010036656 Forming viruses
11/01/2001	US20010036655 Vaccine
11/01/2001	US20010036628 Inoculation, culture product, calibration
11/01/2001	CA2407377A1 Dna & protein binding miniature proteins
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001	CA2407050A1 Alphavirus-based vectors for persistent infection
10/2001
10/31/2001	EP1149917A2 Hepatitis B virus vectors for gene therapy
10/31/2001	EP1149916A2 Defective Adenoviruses and corresponding transcomplementant cell lines
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149905A1 Methods and compositions for polypeptide engineering
10/31/2001	EP1149904A1 Methods and compositions for polypeptide engineering
10/31/2001	EP1149901A1 Pestivirus mutants and vaccines containing the same
10/31/2001	EP0842279B1 Helper viruses for preparing recombinant viral vectors
10/31/2001	DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001	CN1073858C Stabilizer-containing live attenuated hepatitis A vaccine and its preparation
10/30/2001	US6310045 Compositions and methods for cancer immunotherapy
10/30/2001	US6310044 Oligonucleotide therapies for modulating the effects of herpesviruses
10/30/2001	US6309878 Glucose-inducible recombinant viral vector
10/30/2001	US6309650 Attenuated Japanese encephalitis virus adapted to Vero cell and a Japanese encephalitis vaccine
10/30/2001	US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified.
10/30/2001	US6309647 The recombinant viruses and gene products therefrom are useful for eliciting protection against canine distemper virus and/or measles virus.
10/30/2001	US6309644 Parasitic nematode transglutaminase proteins and uses thereof

1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 267